Quantbot Technologies LP Sells 169,205 Shares of Avantor, Inc. (NYSE:AVTR)

Quantbot Technologies LP lessened its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 62.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 101,448 shares of the company's stock after selling 169,205 shares during the quarter. Quantbot Technologies LP's holdings in Avantor were worth $2,624,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Intech Investment Management LLC lifted its stake in Avantor by 1.8% in the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company's stock valued at $616,000 after buying an additional 514 shares during the period. Arizona State Retirement System lifted its position in shares of Avantor by 0.3% during the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company's stock worth $3,955,000 after buying an additional 528 shares in the last quarter. Veracity Capital LLC boosted its stake in shares of Avantor by 1.0% in the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company's stock worth $1,355,000 after buying an additional 543 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Avantor by 2.8% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock valued at $571,000 after acquiring an additional 733 shares in the last quarter. Finally, US Bancorp DE boosted its position in Avantor by 6.2% in the third quarter. US Bancorp DE now owns 12,615 shares of the company's stock worth $326,000 after purchasing an additional 734 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Avantor Price Performance

Shares of AVTR traded up $0.03 during mid-day trading on Thursday, reaching $21.04. 5,572,413 shares of the stock traded hands, compared to its average volume of 6,506,209. The company has a market cap of $14.32 billion, a price-to-earnings ratio of 45.74, a price-to-earnings-growth ratio of 2.56 and a beta of 1.35. Avantor, Inc. has a 1 year low of $19.59 and a 1 year high of $28.00. The firm has a fifty day moving average price of $23.40 and a 200 day moving average price of $23.76. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Barclays cut their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. Wells Fargo & Company lowered their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. UBS Group reduced their price objective on Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a report on Tuesday, October 8th. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research note on Monday, October 28th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, Avantor has a consensus rating of "Moderate Buy" and a consensus target price of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.